Comment
Author: Admin | 2025-04-28
Fourteen companies that make and/or sell over-the-counter cold and flu medicines face a proposed class action in the wake of an FDA advisory panel announcement that the active ingredient phenylephrine is wholly ineffective at treating nasal congestion.If you’ve bought cold and flu medicine containing phenylephrine, let us know here.The 19-page case alleges in particular that the makers of several popular medications—such as Tylenol, Sudafed, Advil and Dayquil—have for years marketed their products as effective at relieving nasal congestion and other cold and flu symptoms, despite knowing that phenylephrine works no better than a placebo. The lawsuit was filed in California on September 12, the same day an FDA advisory committee concluded a two-day review of existing scientific studies on phenylephrine with a unanimous vote that the ingredient does not work to treat nasal congestion. According to the suit, phenylephrine is used as an active ingredient in at least 250 cold and flu products, including, but not limited to: Sudafed Sinus Congestion; Tylenol Cold & Flu Severe; Nyquil Severe Cold & Flu; Theraflu Severe Cold Relief; and Mucinex Sinus Max. The purported decongestant is also found in products sold under generic brand names developed by major retailers such as CVS, Walmart, Target and Walgreens, as well as medicines sold under brand names like Benadryl, Robitussin, Theraflu, Contac, Advil, Alka-Seltzer, Allegra and Zicam, the filing says. Get class action lawsuit news sent to your inbox – sign up for ClassAction.org’s free weekly newsletter here. The complaint names as defendants Johnson & Johnson,
Add Comment